Viveo has acquired three medical product distribution companies for R$ 82 million, significantly enhancing its market position and revenue potential in Brazil's laboratory supplies sector.
Target Information
Viveo, a major player in the healthcare supply industry, has announced the acquisition of three companies specializing in the distribution of medical-hospital products and laboratory reagents for a total of R$ 82 million. The companies acquired include Apijã, Laborsys, and Macromed, which together generated a combined net revenue exceeding R$ 85 million and an EBITDA of R$ 15 million over the past year.
Apijã serves the regions of Goiás and Tocantins, Laborsys has a strong presence in Paraná and Santa Catarina, while Macromed operates in São Paulo and Mato Grosso do Sul. These acquisitions were exclusively advised by FT Aquisições.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
In Brazil, the market for laboratory supplies for both public and private institutions is estimated at R$ 3.5 billion, with reagents representing the most significant s
Similar Deals
Grupo Fleury → Bioclínico and Pretti
2023
Fundo de Investimento em Saúde administrado pelo BTG Pactual → Eco Medical Center
2023
Viveo
invested in
Apijã, Laborsys, Macromed
in 2021
in a Buy & Build / Roll-Up deal
Disclosed details
Transaction Size: $16M
Revenue: $16M
EBITDA: $3M
Enterprise Value: $1,057M
Equity Value: $1,057M
Multiples
EV/EBITDA: 370.9x
EV/Revenue: 66.4x
P/Revenue: 66.4x